Hydrocortison VUAB 100 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

hydrocortison vuab 100 mg

vuab pharma a.s., Česká republika - hydrokortizón - 56 - hormona (lieČiva s hormonÁlnou aktivitou)

Guľôčky vaginálne Feminella Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

guľôčky vaginálne feminella

aziende chimiche riunite angelini francesco a.c.r.a.f. spa viale amelia 70 00181 roma taliansko -

Maltofer Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

maltofer

vifor france, francúzsko - komplexy oxid železitý-polymaltóza - 12 - antianaemica

Kalydeco Európska únia - slovenčina - EMA (European Medicines Agency)

kalydeco

vertex pharmaceuticals (ireland) limited - ivacaftor - cystická fibróza - ostatné produkty dýchacej sústavy - kalydeco tablets are indicated:as monotherapy for the treatment of adults, adolescents, and children aged 6 years and older and weighing 25 kg or more with cystic fibrosis (cf) who have an r117h cftr mutation or one of the following gating (class iii) mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: g551d, g1244e, g1349d, g178r, g551s, s1251n, s1255p, s549n or s549r (see sections 4. 4 a 5. in a combination regimen with tezacaftor/ivacaftor tablets for the treatment of adults, adolescents, and children aged 6 years and older with cystic fibrosis (cf) who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cftr gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t. in a combination regimen with ivacaftor/tezacaftor/elexacaftor tablets for the treatment of adults, adolescents, and children aged 6 years and older with cystic fibrosis (cf) who have at least one f508del mutation in the cftr gene (see section 5. kalydeco granules are indicated for the treatment of infants aged at least 4 months, toddlers and children weighing 5 kg to less than 25 kg with cystic fibrosis (cf) who have an r117h cftr mutation or one of the following gating (class iii) mutations in the cftr gene: g551d, g1244e, g1349d, g178r, g551s, s1251n, s1255p, s549n or s549r (see sections 4. 4 a 5. in a combination regimen with ivacaftor/tezacaftor/elexacaftor for the treatment of cystic fibrosis (cf) in paediatric patients aged 2 to less than 6 years who have at least one f508del mutation in the cftr gene.

INEGY 10 mg/80 mg tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

inegy 10 mg/80 mg tablety

n.v. organon, holandsko - simvastatín a ezetimib - 31 - hypolipidaemica

INEGY 10 mg/40 mg tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

inegy 10 mg/40 mg tablety

n.v. organon, holandsko - simvastatín a ezetimib - 31 - hypolipidaemica

INEGY 10 mg/20 mg tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

inegy 10 mg/20 mg tablety

n.v. organon, holandsko - simvastatín a ezetimib - 31 - hypolipidaemica

INEGY 10 mg/10 mg tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

inegy 10 mg/10 mg tablety

n.v. organon, holandsko - simvastatín a ezetimib - 31 - hypolipidaemica

Vasitimb 10 mg/40 mg tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

vasitimb 10 mg/40 mg tablety

krka, d.d., novo mesto, slovinsko - simvastatín a ezetimib - 31 - hypolipidaemica

Vasitimb 10 mg/20 mg tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

vasitimb 10 mg/20 mg tablety

krka, d.d., novo mesto, slovinsko - simvastatín a ezetimib - 31 - hypolipidaemica